SCHEMBL887176

SCHEMBL887176

COc1ccc(C(c2ccccc2)(c2ccc(OC)cc2)C(O)[C@H]2O[C@@H](n3ccc(N)nc3=O)C[C@@H]2O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
LMNA P02545 3/20 0.37
P2RY2 P41231 3/20 0.37
P2RY4 P51582 3/20 0.37
CACNA1F O60840 2/20 0.37
ALB P02768 2/20 0.37
MAPT P10636 2/20 0.37
CACNA1D Q01668 2/20 0.37
CACNA1S Q13698 2/20 0.37
CACNA1C Q13936 2/20 0.37
PDE3A Q14432 2/20 0.37
P2RY6 Q15077 2/20 0.37
NT5E P21589 1/20 0.37
POLG P54098 2/20 0.36
THRB P10828 1/20 0.36
MTOR P42345 1/20 0.36
MDM2 Q00987 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
ST6GAL1 P15907 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28516266 0.94 POLB (0.38) POLBLMNAP2RY2P2RY4CACNA1F
SCHEMBL8491773 0.92 POLB (0.45) POLBLMNAP2RY2P2RY4CACNA1F
SCHEMBL7199260 0.88 POLB (0.41) POLBLMNAP2RY2P2RY4CACNA1F
SCHEMBL5859682 0.88 POLB (0.41) POLBLMNAP2RY2P2RY4CACNA1F
SCHEMBL2112368 0.86 POLB (0.42) POLBP2RY2P2RY4MAPTP2RY6
SCHEMBL618137 0.86 POLB (0.39) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL7533550 0.85 POLB (0.51) POLBP2RY6NT5E
SCHEMBL2270354 0.85 POLB (0.38) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL332975 0.85 POLB (0.51) POLBP2RY6NT5E
SCHEMBL8607542 0.85 POLB (0.49) POLBLMNAMAPTP2RY6NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107473972-B Nucleoside protective group and preparation thereof 上海兆维科技发展有限公司 2021-01-08 CN disclosed
CN-109232692-A A kind of deoxycytidine class organic synthesis intermediate and preparation method thereof 中国医学科学院放射医学研究所 2019-01-18 CN disclosed
EP-2399611-A2 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metasatases in cancer treatment Antisense Pharma GmbH (DE) 2011-12-28 EP disclosed
US-6596537-B1 Oligonucleotide for use in the treatment of cancer, infections and autoimmune diseases CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-07-22 US disclosed
EP-0119621-A1 Interleukin-2 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-09-26 EP disclosed
EP-0040099-A1 Polynucleotide synthesis ens BIO LOGICALS INC. (CA) 1981-11-18 EP disclosed